MyBlueDotsAspect Biosystems Raises US$115 Million Series B Financing to Advance Bioprinted Tissue Therapeutics MyBlueDots2 months ago01 mins VANCOUVER, British Columbia–(BUSINESS WIRE)– #biotech–Aspect Biosystems secures $115M Series B to advance bioprinted tissue therapeutics, accelerating development of functional cures for serious diseases Post navigation Previous: Resumen: Biocytogen y Acepodia combinan fuerzas para desarrollar anticuerpos biespecíficos y ADC de carga doble para el tratamiento de tumores complejosNext: NorthStar Medical Radioisotopes and YAP Therapeutics Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products
Some animals’ natural biological defenses could inspire new approaches to cancer prevention and treatment in humans MyBlueDots2 days ago 0
‘Overlooked’ scrub typhus may affect 1 in 10 in rural India and be a leading cause of hospitalizations for fever MyBlueDots2 days ago 0